Security key
H5870P110
- Security type / class
- Equity / *W EXP 03/06/202
- Total 13F shares
- 474,769
- Total 13F value
- $1,071,531
- Share change
- -56,410
- SEC-reported price per share
- $2.20
- Number of holders
- 19
- Value change
- -$28,465
- Number of buys
- 3
- Number of sells
- 6
Report period
Q1 2024
Institutions
19
Top holders
10
OCSAW full security history
Ownership snapshot
Full 13F holder table
Oculis Holding AG SEC filings
Oculis Holding AG company facts
Broader feeds
Ownership snapshot
Top reported holders of OCSAW - Oculis Holding AG - *W EXP 03/06/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Pivotal bioVenture Partne...
Disclosed value leader
Pivotal bioVenture Partne...
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $21,211,089
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Pivotal bioVenture Partners Investment Advisor LLC has the largest disclosed position value at $21.21M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Pivotal bioVenture Partners Investment Advisor LLC's linked filing trail.
Disclosed position value
Top 5
Pivotal bioVenture Partners Inves...
$21.21M
Aberdeen Group plc
$15.98M
Nan Fung Group Holdings Ltd
$5.83M
Lombard Odier SCmA Compagnie
$1.05M
BANK OF AMERICA CORP /DE/
$190.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
Company
|
—
denominator unverified
|
$21,211,089
1,888,788 shares
|
— | 31 Dec 2023 |
| Aberdeen Group plc |
13F
Company
|
—
denominator unverified
|
$15,980,151
1,452,741 shares
|
— | 31 Dec 2023 |
| Nan Fung Group Holdings Ltd |
13F
Company
|
—
denominator unverified
|
$5,827,618
518,933 shares
|
— | 31 Dec 2023 |
| Lombard Odier SCmA Compagnie |
13F
Individual
|
—
denominator unverified
|
$1,053,250
95,750 shares
|
— | 31 Dec 2023 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$190,079
16,926 shares
|
— | 31 Dec 2023 |
| NOMURA HOLDINGS INC |
13F
Company
|
—
denominator unverified
|
$139,798
100,350 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
474,769
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
19
Q1 2024 holders
19
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|